Trust Point Inc. Celcuity Inc. Transaction History
Trust Point Inc.
- $1.25 Trillion
- Q2 2024
A detailed history of Trust Point Inc. transactions in Celcuity Inc. stock. As of the latest transaction made, Trust Point Inc. holds 18,821 shares of CELC stock, worth $352,517. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,821
Previous 19,395
2.96%
Holding current value
$352,517
Previous $419 Million
26.41%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding CELC
# of Institutions
83Shares Held
22.9MCall Options Held
24.9KPut Options Held
4K-
Perceptive Advisors LLC New York, NY2.36MShares$44.2 Million1.07% of portfolio
-
Morgan Stanley New York, NY2.35MShares$44 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT1.73MShares$32.4 Million3.06% of portfolio
-
Commodore Capital LP New York, NY1.56MShares$29.1 Million2.9% of portfolio
-
Baker Bros. Advisors LP New York, NY1.55MShares$29.1 Million0.42% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $280M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...